Literature DB >> 23232082

Tropomyosin Ser-283 pseudo-phosphorylation slows myofibril relaxation.

Benjamin R Nixon1, Bin Liu, Beatrice Scellini, Chiara Tesi, Nicoletta Piroddi, Ozgur Ogut, R John Solaro, Mark T Ziolo, Paul M L Janssen, Jonathan P Davis, Corrado Poggesi, Brandon J Biesiadecki.   

Abstract

Tropomyosin (Tm) is a central protein in the Ca(2+) regulation of striated muscle. The αTm isoform undergoes phosphorylation at serine residue 283. While the biochemical and steady-state muscle function of muscle purified Tm phosphorylation have been explored, the effects of Tm phosphorylation on the dynamic properties of muscle contraction and relaxation are unknown. To investigate the kinetic regulatory role of αTm phosphorylation we expressed and purified native N-terminal acetylated Ser-283 wild-type, S283A phosphorylation null and S283D pseudo-phosphorylation Tm mutants in insect cells. Purified Tm's regulate thin filaments similar to that reported for muscle purified Tm. Steady-state Ca(2+) binding to troponin C (TnC) in reconstituted thin filaments did not differ between the 3 Tm's, however disassociation of Ca(2+) from filaments containing pseudo-phosphorylated Tm was slowed compared to wild-type Tm. Replacement of pseudo-phosphorylated Tm into myofibrils similarly prolonged the slow phase of relaxation and decreased the rate of the fast phase without altering activation kinetics. These data demonstrate that Tm pseudo-phosphorylation slows deactivation of the thin filament and muscle force relaxation dynamics in the absence of dynamic and steady-state effects on muscle activation. This supports a role for Tm as a key protein in the regulation of muscle relaxation dynamics.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232082      PMCID: PMC3640754          DOI: 10.1016/j.abb.2012.11.010

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  50 in total

Review 1.  Troponin I: inhibitor or facilitator.

Authors:  S V Perry
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

2.  Effect of phosphorylation on the interaction and functional properties of rabbit striated muscle alpha alpha-tropomyosin.

Authors:  D H Heeley; M H Watson; A S Mak; P Dubord; L B Smillie
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

Review 3.  Calcium, thin filaments, and the integrative biology of cardiac contractility.

Authors:  Tomoyoshi Kobayashi; R John Solaro
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

4.  Identification of a region of troponin I important in signaling cross-bridge-dependent activation of cardiac myofilaments.

Authors:  Patti L Engel; Tomoyoshi Kobayashi; Brandon Biesiadecki; Jonathan Davis; Svetlana Tikunova; Steven Wu; R John Solaro
Journal:  J Biol Chem       Date:  2006-11-12       Impact factor: 5.157

Review 5.  Thin filament-mediated regulation of cardiac contraction.

Authors:  L S Tobacman
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

6.  Calcium dependence of the apparent rate of force generation in single striated muscle myofibrils activated by rapid solution changes.

Authors:  F Colomo; S Nencini; N Piroddi; C Poggesi; C Tesi
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

7.  Altered actin and troponin binding of amino-terminal variants of chicken striated muscle alpha-tropomyosin expressed in Escherichia coli.

Authors:  S E Hitchcock-DeGregori; R W Heald
Journal:  J Biol Chem       Date:  1987-07-15       Impact factor: 5.157

8.  Requirement of amino-terminal modification for striated muscle alpha-tropomyosin function.

Authors:  M Urbancikova; S E Hitchcock-DeGregori
Journal:  J Biol Chem       Date:  1994-09-30       Impact factor: 5.157

9.  Rabbit skeletal muscle alpha alpha-tropomyosin expressed in baculovirus-infected insect cells possesses the authentic N-terminus structure and functions.

Authors:  L Kluwe; K Maeda; A Miegel; S Fujita-Becker; Y Maéda; G Talbo; T Houthaeve; R Kellner
Journal:  J Muscle Res Cell Motil       Date:  1995-04       Impact factor: 2.698

Review 10.  Sarcomeric determinants of striated muscle relaxation kinetics.

Authors:  Corrado Poggesi; Chiara Tesi; Robert Stehle
Journal:  Pflugers Arch       Date:  2004-11-30       Impact factor: 3.657

View more
  20 in total

Review 1.  Phosphorylation of tropomyosin in striated muscle.

Authors:  David H Heeley
Journal:  J Muscle Res Cell Motil       Date:  2013-06-29       Impact factor: 2.698

Review 2.  Designing proteins to combat disease: Cardiac troponin C as an example.

Authors:  Jonathan P Davis; Vikram Shettigar; Svetlana B Tikunova; Sean C Little; Bin Liu; Jalal K Siddiqui; Paul M L Janssen; Mark T Ziolo; Shane D Walton
Journal:  Arch Biochem Biophys       Date:  2016-02-18       Impact factor: 4.013

3.  Tropomyosin pseudo-phosphorylation results in dilated cardiomyopathy.

Authors:  Sudarsan Rajan; Ganapathy Jagatheesan; Natalia Petrashevskaya; Brandon J Biesiadecki; Chad M Warren; Tara Riddle; Stephen Liggett; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  J Biol Chem       Date:  2018-12-19       Impact factor: 5.157

4.  Cardiac troponin I tyrosine 26 phosphorylation decreases myofilament Ca2+ sensitivity and accelerates deactivation.

Authors:  Hussam E Salhi; Shane D Walton; Nathan C Hassel; Elizabeth A Brundage; Pieter P de Tombe; Paul M L Janssen; Jonathan P Davis; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2014-09-22       Impact factor: 5.000

5.  Length dependence of striated muscle force generation is controlled by phosphorylation of cTnI at serines 23/24.

Authors:  Laurin M Hanft; Brandon J Biesiadecki; Kerry S McDonald
Journal:  J Physiol       Date:  2013-07-08       Impact factor: 5.182

Review 6.  Pseudophosphorylation of cardiac myosin regulatory light chain: a promising new tool for treatment of cardiomyopathy.

Authors:  Sunil Yadav; Danuta Szczesna-Cordary
Journal:  Biophys Rev       Date:  2017-01-25

Review 7.  A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium.

Authors:  Fan Bai; Li Wang; Masataka Kawai
Journal:  J Muscle Res Cell Motil       Date:  2013-05-23       Impact factor: 2.698

8.  Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy.

Authors:  Emily M Schulz; Tanganyika Wilder; Shamim A K Chowdhury; Hajer N Sheikh; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  J Biol Chem       Date:  2013-08-19       Impact factor: 5.157

9.  The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.

Authors:  Michelle M Monasky; Domenico M Taglieri; Marcus Henze; Chad M Warren; Megan S Utter; David G Soergel; Jonathan D Violin; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-07-19       Impact factor: 4.733

10.  Conserved Asp-137 is important for both structure and regulatory functions of cardiac α-tropomyosin (α-TM) in a novel transgenic mouse model expressing α-TM-D137L.

Authors:  Sumeyye Yar; Shamim A K Chowdhury; Robert T Davis; Minae Kobayashi; Michelle M Monasky; Sudarsan Rajan; Beata M Wolska; Vadim Gaponenko; Tomoyoshi Kobayashi; David F Wieczorek; R John Solaro
Journal:  J Biol Chem       Date:  2013-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.